The impact of an early ibuprofen treatment protocol on the incidence of surgical ligation of the ductus arteriosus

American Journal of Perinatology

Volumn 27, Issue 1, 2010, Pages 83-90

  Tefft, Robert G ^a  

^a White Memorial Medical Center   (United States)

Author keywords

Ductus arteriosus; Ibuprofen; Indomethacin; Ligation; PDA

Indexed keywords

IBUPROFEN; INDOMETACIN; STEROID; SURFACTANT;

APGAR SCORE; ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DRUG INDICATION; EARLY INTERVENTION; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INCIDENCE; INFANT; INTESTINE PERFORATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PH; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; VERY LOW BIRTH WEIGHT;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LIGATION; MALE; TREATMENT OUTCOME;

EID: 74549221455     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1239492     Document Type: Article

References (41)

1. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld C R. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006 117 1113-1121
2. Hermes-DeSantis E R., Clyman R I. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006 26 (suppl 1) S14-S18 discussion S22-S23
3. Cowan F. Indomethacin, patent ductus arteriosus, and cerebral blood flow. J Pediatr 1986 109 341-344
4. Liem K D., Hopman J CW, Kollée L AA, Oeseburg B. Effects of repeated indomethacin administration on cerebral oxygenation and haemodynamics in preterm infants: combined near infrared spectrophotometry and Doppler ultrasound study. Eur J Pediatr 1994 153 504-509 (Pubitemid 24210282)
5. Kang N S., Yoo K H., Cheon H et al. Indomethacin treatment decreases renal blood flow velocity in human neonates. Biol Neonate 1999 76 261-265
6. Coombs R C., Morgan M E., Durbin G M., Booth I W., McNeish A S. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990 65 (10 Spec No) 1067-1071
7. Akima S, Kent A, Reynolds G J., Gallagher M, Falk M C. Indomethacin and renal impairment in neonates. Pediatr Nephrol 2004 19 490-493
8. Attridge J T., Clark R, Walker M W., Gordon P V. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006 26 93-99
9. Fujii A M., Brown E, Mirochnick M, O'Brien S, Kaufman G. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 2002 22 535-540
10. Fowlie P W., Davis P G. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003 88 F464-F466
11. Pinhiero J M., Schulman J. Increasing incidence of patent ductus arteriosus (PDA) and PDA ligation in very low birth weight neonates [abstract]. Paediatric Academic Societies Annual Meeting 2005 Abstract 57 583
12. Van Overmeire B, Smets K, Lecoutere D et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000 343 674-681
13. Lago P, Bettiol T, Salvadori S et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002 161 202-207
14. Su P-H, Chen J-Y, Su C-M, Huang T C., Lee H S. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int 2003 45 665-670
15. Thomas R L., Parker G C., Van Overmeire B, Aranda J V. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005 164 135-140
16. Aranda J V., Thomas R. Systematic review: intravenous ibuprofen in preterm newborns. Semin Perinatol 2006 30 114-120
17. Su B-H, Lin H-C, Chiu H-Y et al. Comparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008 93 F94-999
18. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997 131 549-554
19. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli F F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999 135 733-738
20. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards A D. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000 47 36-42
21. Romagnoli C, De Carolis M P., Papacci P et al. Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin Pharmacol Ther 2000 67 676-683
22. Varvarigou A, Bardin C L., Beharry K, Chemtob S, Papageorgiou A, Aranda J V. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996 275 539-544
23. Van Overmeire B, Follens I, Hartmann S et al. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997 76 F179-F184
24. De Carolis M P., Romagnoli C, Polimeni V et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 2000 159 364-368
25. Dani C, Bertini G, Reali M F. et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Paediatr 2000 89 1369-1374
26. Van Overmeire B, Allegaert K, Casaer A et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004 364 1945-1949
27. Dani C, Bertini G, Pezzati M et al, IntraVentricular Ibuprofen Study Group. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005 115 1529-1535
28. Shah S S., Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006 CD004213
29. Koehne P S., Bein G, Alexi-Meskhishvii V et al. Patent ductus arteriosus in very low birthweight infants: complications of pharmacologic and surgical treatment. J Perinat Med 2001 29 327-334
30. Moin F, Kennedy K A., Moya F R. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol 2003 20 313-320
31. Noori S, Friedlich P, Seri I, Wong P. Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr 2007 150 597-602
32. Kabra N S., Schmidt B, Roberts R S., Doyle L W., Papile L, Fanaroff A, Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007 150 229-234, 234, e1
33. Chorne N, Leonard C, Piecuch R, Clyman R I. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007 119 1165-1174
34. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed 2000 82 F188-F194
35. Osborn D A., Evans N, Kluckow M. Effect of early targeted indomethacin on the ductus arteriosus and blood flow to the upper body and brain in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2003 88 F477-F482
36. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr 2000 137 68-72
37. Sarkar S, Dechert R, Schumacher R E., Donn S M. Is refractory hypotension in preterm infants a manifestation of early ductal shunting? J Perinatol 2007 27 353-358
38. Alfaleh K, Smyth J A., Roberts R S. et al. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 2008 121 e233-e238
39. El-Khuffash A F., Molloy E J., Walsh K et al. Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants. J Pediatr 2008 153 350-353
40. El-Khuffash A, Barry D, Walsh K, Davis P G., Molloy E J. Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed 2008 93 F407-F412
41. Aranda J V., Clyman R, Cox B et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 2009 26 235-245